A Randomized, Split-face Clinical Study on Comparative Ultrasound Analysis of Two Hyaluronic Acid Fillers for Midface Correction
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Galderma R&D
- Enrollment
- 11
- Locations
- 1
- Primary Endpoint
- Assess and compare tissue aggregation and visualization of Hyaluronic Acid fillers using ultrasound
Overview
Brief Summary
To assess and compare tissue aggregation and visualization of two Hyaluronic Acid fillers via ultrasound
Detailed Description
This is a randomized, split-face, subject-blinded, comparative study to assess and compare tissue aggregation and visualization of two Hyaluronic Acid fillers via ultrasound.
This study is designed to enroll and randomize approximately 15 subjects in a 1:1 ratio of treatment to Restylane Contour or Juvederm Voluma. All subjects are to have midface volume loss and contour deficiency.
Eligible subjects are randomized to receive treatment were injected by the Treating Investigator at Baseline. The method of injection is at the discretion of the Treating Investigator. A sufficient amount of product is injected to achieve optimal correction of the midface, in the opinion of the Treating Investigator and subject.
At the 4-week visit, after all study procedures for the visit are completed, treated subjects have the option of receiving a touch-up treatment to achieve optimal aesthetic improvement. At the 6-month, 9-month, and 12-month visits, similar study procedures are performed.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Masking Description
Subjects are blinded to treatment assignment to each side of their faces.
Eligibility Criteria
- Ages
- 22 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Subject with midface volume loss and contour deficiency
- •Ability of giving consent for participation in the study
- •Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments
Exclusion Criteria
- •History of allergy or hypersensitivity to lidocaine and/or injectable hyaluronic acid
- •Previous permanent or semi-permanent implant in proposed treatment area
- •Previous biodegradable tissue augmentation therapy in the proposed treatment area within 12 months prior to the baseline visit
- •History of other facial treatment/procedure at the study area (midface) in the previous 6 months that would potentially interfere with study injections (e.g., facial surgery, oral surgery, resurfacing, mesotherapy, lipolytic injections, botulinum toxin injections)
Outcomes
Primary Outcomes
Assess and compare tissue aggregation and visualization of Hyaluronic Acid fillers using ultrasound
Time Frame: Immediately post-treatment, 4 weeks, 6 months, 9 months, and 12 months after baseline
Change in filler properties within the skin tissues. Filler properties include size, shape, and aggregation at different facial expressions.
Secondary Outcomes
- Evaluate subject satisfaction using self-assessment questionnaire(4 weeks, 6 months, 9 months, and 12 months after baseline)
- Evaluate volume change in the treated areas using 3D imaging(4 weeks, 6 months, 9 months, and 12 months after baseline)